Balanced news tone
News Sentiment
NOVO-B sentiment intelligence
Novo Nordisk A/S news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
87/100 classification confidence.
directly relevant articles
high-authority source matches
+2.4% over one week, +12.6% over four weeks, trend inactive, and below fair value.
Novo Nordisk stock trades near record levels as obesity and diabetes momentum supports earnings
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Novo Nordisk stock trades near record levels as obesity and diabetes momentum supports earnings
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 18 Jul 2026 05:55
- Source
- ad-hoc-news.de
Novo Nordisk: EU Approval of Wegovy Pill Expands Opportunity, but Cash Pay Raises Systematic Risk
- Tone
- Positive 66/100
- Event
- Regulatory and legal
- Published
- 17 Jul 2026 17:59
- Source
- Morningstar
Novo Nordisk's Steady Innovation in Diabetes and Obesity Have Created a Wide Moat
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 16:40
- Source
- Morningstar
Novo Nordisk: The Oral Wegovy Promise (NYSE:NVO)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 15:12
- Source
- Seeking Alpha
Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to Note
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 16 Jul 2026 21:45
- Source
- Market source
Novo Nordisk Stock Up Over 2% Premarket Today — Thanks To OpenAI Tie-Up
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 20:40
- Source
- Stocktwits
Novo Nordisk (CPSE:NOVO B) Stock Fair Value Edges Higher As Analysts Rework Growth Assumptions
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 15 Jul 2026 23:15
- Source
- Market source
Why Novo Nordisk (NVO) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 15:37
- Source
- Quiver Quantitative
Two Overhyped GLP-1 Stocks Present Buying Opportunities on Dips, with Novo Nordisk and Kailera Therapeutics Each Offering Unique Highlights
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 06:28
- Source
- NAI500
[6-K] NOVO NORDISK A S Current Report (Foreign Issuer) | NVO SEC Filing - Form 6-K
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 13:25
- Source
- Stock Titan
Novo Nordisk (NYSE: NVO) details progress on DKK 15B share repurchase
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 06 Jul 2026 07:00
- Source
- Stock Titan
Novo Nordisk: Stock Price Is Only Beginning To Catch Up With Business Fundamentals (NVO)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 07:00
- Source
- Seeking Alpha
Novo Nordisk (NVO) Stock May Be 48% Undervalued On Medicare GLP 1 Coverage
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Market source
Novo Nordisk (NVO) Upgraded to Buy at Nordea. Here is Why
- Tone
- Positive 84/100
- Event
- Analyst action
- Published
- 30 Jun 2026 07:00
- Source
- Market source
Novo Nordisk (NYSE: NVO) Stock Price Gains Ground As UK Approves Wegovy Pill For Weight Management
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- foreignpolicyjournal.com
Novo Nordisk (NYSE: NVO) repurchases 20,959,179 shares in 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Stock Titan
Here is why Novo Nordisk A/S (NVO) is among the Best Longevity and Anti-Aging Stocks to Buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Market source
Novo Nordisk A/S - share repurchase programme
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 22 Jun 2026 07:00
- Source
- GlobeNewswire
Novo Nordisk: The Danish Empire Strikes Back (NYSE:NVO)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Seeking Alpha
Novo Nordisk (NVO) repurchases 19.9M B shares under 2026 plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
Novo Nordisk: Deeply Undervalued With A Return To Growth In 2027 (NYSE:NVO)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Seeking Alpha
Here's What I Think Is Really Going on With Novo Nordisk Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- The Motley Fool
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- Market source
Novo Nordisk - Enough Is Enough: 5 Reasons It's Time To Sell (Rating Downgrade)
- Tone
- Negative 18/100
- Event
- Analyst action
- Published
- 13 Mar 2026 07:00
- Source
- Seeking Alpha
Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Feb 2026 08:00
- Source
- Reuters
Novo Nordisk Trial Flop Ripples Through Denmark’s Stock Market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Feb 2026 08:00
- Source
- Bloomberg.com
Novo Nordisk sinks 16% after weight loss drug fails to match Eli Lilly's in trial
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 23 Feb 2026 08:00
- Source
- CNBC
Novo Nordisk shares rebound as FDA targets illegal drug copies
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Feb 2026 08:00
- Source
- Reuters
Novo Nordisk's sales increased by 6% in Danish kroner and by 10% at constant exchange rates to DKK 309.1 billion in 2025
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 03 Feb 2026 08:00
- Source
- Market source